| scholarly article | Q13442814 |
| P356 | DOI | 10.4161/BIOE.23574 |
| P953 | full work available online at | http://www.tandfonline.com/doi/pdf/10.4161/bioe.23574 |
| https://doi.org/10.4161/bioe.23574 | ||
| https://europepmc.org/articles/PMC3937199 | ||
| https://europepmc.org/articles/PMC3937199?pdf=render | ||
| https://www.tandfonline.com/doi/pdf/10.4161/bioe.23574?needAccess=true | ||
| P932 | PMC publication ID | 3937199 |
| P698 | PubMed publication ID | 23327986 |
| P50 | author | Arun K. Bhunia | Q38320475 |
| Mary Anne Roshni Amalaradjou | Q41641488 | ||
| P2860 | cites work | Lactobacilli expressing variable domain of llama heavy-chain antibody fragments (lactobodies) confer protection against rotavirus-induced diarrhea | Q79327324 |
| The health burden of Campylobacter infection and the impact of antimicrobial resistance: playing chicken | Q79719613 | ||
| Secretion of human interferon-beta 1b by recombinant Lactococcus lactis | Q81513209 | ||
| Battle of the bugs | Q81931912 | ||
| New insights into the impact of the intestinal microbiota on health and disease: a symposium report | Q83284775 | ||
| Nasal immunization of mice with Lactobacillus casei expressing the pneumococcal surface protein C primes the immune system and decreases pneumococcal nasopharyngeal colonization in mice | Q83861773 | ||
| A Paratransgenic Strategy for the Control of Chagas Disease | Q24549209 | ||
| Foodborne illness acquired in the United States--major pathogens | Q24603736 | ||
| The dynamics of norovirus outbreak epidemics: recent insights | Q24609923 | ||
| Genetically modified Streptococcus mutans for the prevention of dental caries | Q28205837 | ||
| A review of vaccine research and development: human enteric infections | Q28297809 | ||
| Identification and characterization of microcin S, a new antibacterial peptide produced by probiotic Escherichia coli G3/10 | Q28482036 | ||
| LAP, an alcohol acetaldehyde dehydrogenase enzyme in Listeria, promotes bacterial adhesion to enterocyte-like Caco-2 cells only in pathogenic species | Q28910428 | ||
| Quorum sensing: cell-to-cell communication in bacteria | Q29547325 | ||
| Magnitude and impact of diarrheal diseases | Q30309920 | ||
| New approaches to making the microenvironment of the female reproductive tract hostile to HIV. | Q30398454 | ||
| Protection against Yersinia pseudotuberculosis infection conferred by a Lactococcus lactis mucosal delivery vector secreting LcrV. | Q33398933 | ||
| Analysis of foodborne outbreak data reported internationally for source attribution | Q33403950 | ||
| Food-borne diseases - the challenges of 20 years ago still persist while new ones continue to emerge. | Q33531000 | ||
| Adjuvant effects for oral immunization provided by recombinant Lactobacillus casei secreting biologically active murine interleukin-1{beta} | Q33613453 | ||
| Targeting the human microbiome with antibiotics, probiotics, and prebiotics: gastroenterology enters the metagenomics era | Q33939802 | ||
| Engineered bacterial communication prevents Vibrio cholerae virulence in an infant mouse model | Q33953097 | ||
| N-terminal Gly(224)-Gly(411) domain in Listeria adhesion protein interacts with host receptor Hsp60 | Q33954581 | ||
| Recombinant probiotic expressing Listeria adhesion protein attenuates Listeria monocytogenes virulence in vitro | Q34123613 | ||
| Prevention of vaginal SHIV transmission in macaques by a live recombinant Lactobacillus. | Q34198191 | ||
| Listeria monocytogenes Uses Listeria Adhesion Protein (LAP) To Promote Bacterial Transepithelial Translocation and Induces Expression of LAP Receptor Hsp60 | Q34309752 | ||
| Heterologous expression of BetL, a betaine uptake system, enhances the stress tolerance of Lactobacillus salivarius UCC118 | Q34432120 | ||
| Safety assessment of probiotics for human use | Q34503589 | ||
| Reducing the carriage of foodborne pathogens in livestock and poultry | Q34538443 | ||
| Probiotic bifidobacteria protect mice from lethal infection with Shiga toxin-producing Escherichia coli O157:H7. | Q34546569 | ||
| Recombinant bacteriophage lysins as antibacterials | Q34558237 | ||
| Intracellular accumulation of trehalose protects Lactococcus lactis from freeze-drying damage and bile toxicity and increases gastric acid resistance | Q35215742 | ||
| Engineering microbes to sense and eradicate Pseudomonas aeruginosa, a human pathogen. | Q35458523 | ||
| Ionophores: their use as ruminant growth promotants and impact on food safety | Q35540643 | ||
| Genetically engineered probiotics | Q35542652 | ||
| Heat shock protein 60 acts as a receptor for the Listeria adhesion protein in Caco-2 cells. | Q35550248 | ||
| Mucosal and Systemic Immune Responses Induced by Recombinant Lactobacillus spp. Expressing the Hemagglutinin of the Avian Influenza Virus H5N1 | Q35739107 | ||
| Engineering commensal bacteria for prophylaxis against infection | Q36074828 | ||
| Construction and immunological evaluation of dual cell surface display of HIV-1 gag and Salmonella enterica serovar Typhimurium FliC in Lactobacillus acidophilus for vaccine delivery | Q36191696 | ||
| Designer probiotics for prevention of enteric infections. | Q36389297 | ||
| Exopolysaccharides produced by intestinal Bifidobacterium strains act as fermentable substrates for human intestinal bacteria. | Q36844955 | ||
| Dendritic cell targeting of Bacillus anthracis protective antigen expressed by Lactobacillus acidophilus protects mice from lethal challenge | Q37110110 | ||
| Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria | Q37111626 | ||
| Toll-like receptor and innate cytokine responses induced by lactobacilli colonization and human rotavirus infection in gnotobiotic pigs. | Q37121858 | ||
| Gastroenterology in developing countries: issues and advances | Q37233997 | ||
| Indications and challenges of probiotics, prebiotics, and synbiotics in the management of arthralgias and spondyloarthropathies in inflammatory bowel disease | Q37275393 | ||
| Probiotics and gastrointestinal disease: successes, problems and future prospects | Q37460752 | ||
| Prospects of photosensitization in control of pathogenic and harmful micro-organisms | Q37490180 | ||
| The economics of enteric infections: human foodborne disease costs | Q37490291 | ||
| Anti-virulence strategies to combat bacteria-mediated disease | Q37676924 | ||
| Bacteriophage for biocontrol of foodborne pathogens: calculations and considerations | Q37705524 | ||
| Probiotics and prebiotics in animal feeding for safe food production | Q37728688 | ||
| Interaction of probiotics and pathogens--benefits to human health? | Q37736076 | ||
| Norovirus as a Foodborne Disease Hazard | Q37866885 | ||
| Probiotic lactic acid bacteria in the gastro-intestinal tract: health benefits, safety and mode of action. | Q37915041 | ||
| Development of Vaccine Delivery Vehicles Based on Lactic Acid Bacteria | Q37928954 | ||
| Mucosal Vaccination and Therapy with Genetically Modified Lactic Acid Bacteria | Q37963078 | ||
| Novel Natural Food Antimicrobials | Q37990019 | ||
| Probiotics, their health benefits and applications for developing healthier foods: a review | Q38008464 | ||
| Designing probiotics with respect to the native microbiome. | Q38008468 | ||
| Modern approaches in probiotics research to control foodborne pathogens. | Q38049200 | ||
| Bacteriophages for Detection and Control of Bacterial Pathogens in Food and Food-Processing Environment | Q38049201 | ||
| Effect of lactic acid bacteria probiotic culture for the treatment of Salmonella enterica serovar Heidelberg in neonatal broiler chickens and turkey poults | Q38428872 | ||
| Surface Display of N-Terminally Anchored Invasin by Lactobacillus plantarum Activates NF-κB in Monocytes | Q39329973 | ||
| Lactobacillus plantarum AS1 binds to cultured human intestinal cell line HT-29 and inhibits cell attachment by enterovirulent bacterium Vibrio parahaemolyticus | Q39489129 | ||
| Oral immunization with live Lactococcus lactis expressing rotavirus VP8 subunit induces specific immune response in mice. | Q39550884 | ||
| Targeted expression of anthrax protective antigen by Lactobacillus gasseri as an anthrax vaccine | Q39846065 | ||
| Expression of LAP, a SecA2-dependent secretory protein, is induced under anaerobic environment | Q39849476 | ||
| Probiotics in the intensive care unit: why controversies and confusion abound | Q40074715 | ||
| Effect of the continuous intake of probiotic-fermented milk containing Lactobacillus casei strain Shirota on fever in a mass outbreak of norovirus gastroenteritis and the faecal microflora in a health service facility for the aged | Q40326901 | ||
| Lactococcus lactis expressing either Staphylococcus aureus fibronectin-binding protein A or Listeria monocytogenes internalin A can efficiently internalize and deliver DNA in human epithelial cells | Q42116538 | ||
| Biocontainment strategies for live lactic acid bacteria vaccine vectors | Q42161475 | ||
| Probiotic bacteria are antagonistic to Salmonella enterica and Campylobacter jejuni and influence host lymphocyte responses in human microbiota-associated immunodeficient and immunocompetent mice | Q43501391 | ||
| Use of VSL[sharp]3 in the treatment of rotavirus diarrhea in children: preliminary results | Q43744503 | ||
| Development of a chromosome-plasmid balanced lethal system for Lactobacillus acidophilus with thyA gene as selective marker | Q44101765 | ||
| Probiotic Lactobacillus casei expressing human lactoferrin elevates antibacterial activity in the gastrointestinal tract | Q44481793 | ||
| Lactobacillus reuteri ATCC 55730 and L22 display probiotic potential in vitro and protect against Salmonella-induced pullorum disease in a chick model of infection | Q44694770 | ||
| Probiotics and prebiotics to combat enteric infections and HIV in the developing world: a consensus report | Q44755314 | ||
| Innate and acquired immune responses induced by recombinant Lactobacillus casei displaying flagellin-fusion antigen on the cell-surface | Q44856851 | ||
| Inhibition of growth of Shiga toxin-producing Escherichia coli by nonpathogenic Escherichia coli | Q46240040 | ||
| Intragastric administration with recombinant Lactococcus lactis producing heme oxygenase-1 prevents lipopolysaccharide-induced endotoxemia in rats | Q46636524 | ||
| Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. | Q49073992 | ||
| Lactobacillus fermentum isolated from human colonic mucosal biopsy inhibits the growth and adhesion of enteric and foodborne pathogens | Q50042262 | ||
| A flagellin-producing Lactococcus strain: interactions with mucin and enteropathogens. | Q50043585 | ||
| Protective effect of Lactobacillus casei strain Shirota against lethal infection with multi-drug resistant Salmonella enterica serovar Typhimurium DT104 in mice | Q50045208 | ||
| Anti-infective mechanisms induced by a probiotic Lactobacillus strain against Salmonella enterica serovar Typhimurium infection | Q50050283 | ||
| Evaluation of a Lactobacillus-based probiotic culture for the reduction of Salmonella enteritidis in neonatal broiler chicks | Q50065903 | ||
| Immunization of mice with Lactobacillus casei expressing intimin fragments produces antibodies able to inhibit the adhesion of enteropathogenic Escherichia coli to cultivated epithelial cells | Q50231847 | ||
| Mice protected by oral immunization with Lactobacillus reuteri secreting fusion protein of Escherichia coli enterotoxin subunit protein | Q50672506 | ||
| Lactobacillus acidophilus expressing recombinant K99 adhesive fimbriae has an inhibitory effect on adhesion of enterotoxigenic Escherichia coli | Q53609370 | ||
| Immunomodulating Activity of Lactobacillus paracasei subsp. paracasei NTU 101 in Enterohemorrhagic Escherichia coli O157H7-Infected Mice | Q54377737 | ||
| Manufacturing process influences properties of probiotic bacteria | Q54402782 | ||
| A Bifidobacterium-based synbiotic product to reduce the transmission of C. jejuni along the poultry food chain | Q56981149 | ||
| Bioengineered Probiotics – A Solution to Broaden Probiotics Efficacy! | Q58620648 | ||
| Improving gastric transit, gastrointestinal persistence and therapeutic efficacy of the probiotic strain Bifidobacterium breve UCC2003 | Q59697996 | ||
| Bacterial stress response in Listeria monocytogenes: jumping the hurdles imposed by minimal processing | Q59698053 | ||
| Immunization with recombinant Lactobacillus casei strains producing K99, K88 fimbrial protein protects mice against enterotoxigenic Escherichia coli | Q64449013 | ||
| Reduction of fecal shedding of enterohemorrhagic Escherichia coli O157:H7 in lambs by feeding microbial feed supplement | Q73407888 | ||
| Oral vaccination of mice against tetanus with recombinant Lactococcus lactis | Q73502185 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lactic acid bacteria | Q13360072 |
| probiotics | Q1816730 | ||
| P304 | page(s) | 379-387 | |
| P577 | publication date | 2013-01-17 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Bioengineered | Q26842570 |
| P1476 | title | Bioengineered probiotics, a strategic approach to control enteric infections | |
| P478 | volume | 4 |
| Q38445432 | Avian rotavirus enteritis - an updated review |
| Q38806283 | Bioengineered probiotics as a new hope for health and diseases: an overview of potential and prospects |
| Q46259284 | Biological Containment of Genetically Modified Bacillus subtilis |
| Q44476253 | Evaluating effects of penicillin treatment on the metabolome of rats |
| Q40037758 | Ghost probiotics with a combined regimen: a novel therapeutic approach against the Zika virus, an emerging world threat |
| Q92252044 | Internalin AB-expressing recombinant Lactobacillus casei protects Caco-2 cells from Listeria monocytogenes-induced damages under simulated intestinal conditions |
| Q93120863 | Lactobacillus casei expressing Internalins A and B reduces Listeria monocytogenes interaction with Caco-2 cells in vitro |
| Q93598991 | Landes Highlights |
| Q46248509 | Microbiome at the Frontier of Personalized Medicine |
| Q92865756 | Probiotic Bacteria: A Promising Tool in Cancer Prevention and Therapy |
| Q33651733 | Probiotic engineering: towards development of robust probiotic strains with enhanced functional properties and for targeted control of enteric pathogens. |
| Q104459094 | Receptor-targeted engineered probiotics mitigate lethal Listeria infection |
| Q37396688 | Synergistic action of cinnamaldehyde with silver nanoparticles against spore-forming bacteria: a case for judicious use of silver nanoparticles for antibacterial applications |
| Q90224285 | The Potential Impact of Probiotics on the Gut Microbiome of Athletes |
Search more.